Otis W. Brawley, M.D., MACP, FASCO, FACE
Bloomberg Distinguished Professor of Oncology and Epidemiology Johns Hopkins University 1550 Orleans St CRB 1M-14 Baltimore, MD 21287, Otis.Brawley@JHU.edu Michael J. Cima, Ph.D. Professor David H. Koch Professor of Engineering Faculty Director of the Lemelson-MIT Program Department of Materials Science and Engineering Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology 77 Massachusetts Avenue Bldg 76 Room 653G Cambridge MA 02139 617-253-6877, mjcima@mit.edu Alan D'Andrea, M.D. Director, Susan F. Smith Center for Women's Cancers The Fuller-American Cancer Society Professor, Dana-Faber Cancer Institute 450 Brookline Avenue, HIM 243 Boston, MA 02115 (617) 632-2080, alan_dandrea@dfci.harvard.edu |
Mark Manfredi, Ph.D.
Chief Scientific Officer Kyn Therapeutics 400 Technology Square 10th Floor Cambridge, MA 02139 (857) 201-2764, mark@kyntherapeutics.com Olufunmilayo Olopade, M.B.B.S., F.A.ACR. Professor of Medicine and Human Genetics The University of Chicago 5841 S Maryland Avenue, MC 2115 Chicago, IL 60637 (773) 702-1632, folopade@medicine.bsd.uchicago.edu Drew M. Pardoll M.D., Ph.D.
Abeloff Professor of Oncology Director, Bloomberg~Kimmel Institute for Cancer Immunotherapy Director, Cancer Immunology Program The Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School of Medicine 1650 Orleans Street, CRB1 Room 444 Baltimore, MD 21287 (410) 955-7866, dpardol1@jhmi.edu |
William L. Dahut, M.D.
Chief Scientific Officer American Cancer Society, Inc. 655 15th Street NW Suite 503 Washington, DC 20005 (800)227-2345, William.dahu@cancer.org Tona M. Gilmer, Ph.D.
C-Founder & CSO XRad Therapeutics 3211 Moores Mill Rd. Rougemont, NC 27572 (919) 412-7377, tgilmer10@gmail.com Peter A. Jones, Ph.D., D.Sc.
Chief Scientific Officer Van Andel Research Institute 333 Bostwick Ave., N.E. Grand Rapids, Michigan 49503 (616) 234-5685, peter.jones@vai.org Carl June, M.D.
Richard W. Vague Professor in Immunotherapy University of Pennsylvania 409 Baird Road Merion, PA 19066 (215) 573-3269, cjune@upenn.edu William G. Kaelin, Jr., M.D.
Sidney Farber Professor of Medicine Dana-Farber Cancer Institute and Howard Hughes Medical Institute 450 Brookline Avenue, Mayer 457 Boston, MA 02115 (617) 632-3975, william_kaelin@dfci.harvard.edu Michael B. Kastan, M.D., Ph.D.
Executive Director Duke Cancer Institute Mail Box 3917 10 Bryan Searle Drive Seeley Mudd Building Durham, NC 27710 (919) 684-3052, michael.kastan@duke.edu Karen E. Knudsen, MBA, Ph.D.
Chief Executive Officer American Cancer Society, Inc. 1818 Market Street Philadelphia, PA 19103 (800)227-2345, karen.knudsen@cancer.org Scott W. Lowe, Ph.D.
Chair, Cancer Biology & Genetics Program, MSKCC Memorial Sloan Kettering Cancer Center 1275 York Avenue, Box 373 New York, NY 10065 (646) 888-3342, lowes@mskcc.org |
Robert Radinsky, Ph.D.
Vice President, Oncology Scientific Innovations Janssen Research & Development 255 Main Street, 7th floor Cambridge, MA 02142 (215) 450-6110, rradinsk@its.jnj.com Mark Rolfe, Ph.D.
Corporate Vice President Protein Homeostasis Research & Early Development Celgene Corporation (415) 876-8300, mrolfe@celgene.com Christian Rommel, Ph.D.
Global Head Oncology Roche Pharma Research and Early Development Roche Innovation Center Basel F. Hoffmann-La Roche Ltd Grenzacherstrasse 124 (B.52, R.11.04) CH-4070 Basel Switzerland +41 61 682 18 34, Christian.rommel@roche.com Brid M. Ryan, Ph.D., MPH
Vice President of Immune-Oncology Research MiNA Therapeutics 36 Bassett Road London, W106JL United Kingdom +44-7824453556, bridmryan.gmail.com Suzanne Topalian, M.D. Professor, Johns Hopkins University School of Medicine 1550 Orleans St., CRB2-508 Baltimore, MD 21287 (410) 502-8218, stopali1@jhmi.edu James Allison, Ph.D.
Emeritus Stephen Chanock, M.D.
Emeritus William H. Farland, Ph.D.
Emeritus Levi A. Garraway, M.D., Ph.D.
Emeritus David G. Kaufman, M.D., Ph.D.
Emeritus Stuart H. Yuspa, M.D.
Emeritus |
|
BASIC INFORMATION
IMAGE GALLERIES
|
SPONSOR LINKS
|